OKYO Pharma Limited (OKYO)
OKYO Pharma Statistics
Share Statistics
OKYO Pharma has 33.89M shares outstanding. The number of shares has increased by 1.96% in one year.
Shares Outstanding | 33.89M |
Shares Change (YoY) | 1.96% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 0.13% |
Shares Floating | 24.54M |
Failed to Deliver (FTD) Shares | 90.3K |
FTD / Avg. Volume | 63.67% |
Short Selling Information
The latest short interest is 208.3K, so 0.61% of the outstanding shares have been sold short.
Short Interest | 208.3K |
Short % of Shares Out | 0.61% |
Short % of Float | 0.85% |
Short Ratio (days to cover) | 2.26 |
Valuation Ratios
The PE ratio is -2563.69 and the forward PE ratio is null. OKYO Pharma's PEG ratio is 25.66.
PE Ratio | -2563.69 |
Forward PE | n/a |
PS Ratio | 0 |
Forward PS | null |
PB Ratio | -7.34 |
P/FCF Ratio | -4.55 |
PEG Ratio | 25.66 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for OKYO Pharma Limited.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.21, with a Debt / Equity ratio of 0.
Current Ratio | 0.21 |
Quick Ratio | 0.21 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | -0.01 |
Financial Efficiency
Return on equity (ROE) is 0% and return on capital (ROIC) is 0.27%.
Return on Equity (ROE) | 0% |
Return on Assets (ROA) | -0.01% |
Return on Capital (ROIC) | 0.27% |
Revenue Per Employee | $0 |
Profits Per Employee | $-5,608.49 |
Employee Count | 3 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 22.42 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -13.7% in the last 52 weeks. The beta is -3.37, so OKYO Pharma's price volatility has been lower than the market average.
Beta | -3.37 |
52-Week Price Change | -13.7% |
50-Day Moving Average | 1.1 |
200-Day Moving Average | 1.15 |
Relative Strength Index (RSI) | 67.12 |
Average Volume (20 Days) | 141.82K |
Income Statement
Revenue | n/a |
Gross Profit | -7.51K |
Operating Income | -15.75K |
Net Income | -16.83K |
EBITDA | -15.75K |
EBIT | n/a |
Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 826.85K in cash and 0 in debt, giving a net cash position of 826.85K.
Cash & Cash Equivalents | 826.85K |
Total Debt | 0 |
Net Cash | 826.85K |
Retained Earnings | -142.52M |
Total Assets | - |
Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -9.49M and capital expenditures -3, giving a free cash flow of -9.49M.
Operating Cash Flow | -9.49M |
Capital Expenditures | -3 |
Free Cash Flow | -9.49M |
FCF Per Share | -0.32 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
OKYO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0% |
FCF Yield | -22.23% |
Analyst Forecast
The average price target for OKYO is $7, which is 455.6% higher than the current price. The consensus rating is "Buy".
Price Target | $7 |
Price Target Difference | 455.6% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Scores
Altman Z-Score | null |
Piotroski F-Score | null |